<?xml version="1.0" encoding="UTF-8"?>
<p id="p0100">Gametes obtained from patients with other viral illnesses, such as human immunodeficiency virus and hepatitis, must be treated with special precautions aimed at reducing exposure of the noninfected partner and cross-contamination of reproductive tissue within the laboratory (
 <xref rid="bib30" ref-type="bibr">30</xref>). These precautions are not recommended currently for SARS–CoV-2, given the lack of evidence for transmission through blood or sexual contact (
 <xref rid="bib31" ref-type="bibr">31</xref>). Similarly, there is no current recommendation for screening oocyte or sperm donors for SARS–CoV-2. These are areas in which further investigation is necessary to assure the safety of stored gametes and the safety of patients undergoing assisted reproduction.
</p>
